MSH2 and Leigh syndrome: Studies suggest that in EC-LS patients, MSH2 mutations are the most common (50%–66%), followed by MLH1 (24%–40%), MSH6 (10%–13%), and PMS2 (<5%) (Møller et al., 2017).